|
Real-time
Boerse Muenchen
16:44:02 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 0.5850 EUR | -3.31% |
|
-58.28% | - |
| 08-31 | Karyopharm Therapeutics Submits Supplemental New Drug Application to the Fda for Xpovio Plus Ruxolitinib for Patients with Myelofibrosis | CI |
| 08-29 | Karyopharm Therapeutics Inc. - Special Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.26% | -2.29% | +2.99% | -3.55% | +7.71% | +36.97% | +104.79% | +408.01% | +1,320.76% | 1,019B | |
| +0.73% | -4.78% | -5.33% | -1.75% | +23.11% | +35.41% | +61.62% | +59.33% | +114.55% | 610B | |
| +0.35% | +1.29% | +7.20% | +4.68% | +16.72% | +15.86% | +79.90% | +143.95% | +324.46% | 470B | |
| +1.72% | -4.92% | -4.39% | +11.96% | +34.85% | +59.84% | +36.64% | +75.97% | +126.52% | 344B | |
| +0.26% | -1.58% | -2.02% | +2.70% | +6.58% | +21.97% | +41.79% | +0.97% | +45.33% | 336B | |
| +0.60% | -3.48% | -9.57% | -8.40% | +6.92% | +11.37% | +34.33% | +54.18% | +51.79% | 266B | |
| +1.65% | -4.27% | -0.40% | -17.28% | -13.28% | -5.47% | +9.69% | +35.03% | +137.17% | 241B | |
| -0.09% | -4.97% | +2.40% | +9.87% | +23.00% | +36.88% | +50.52% | +91.73% | +141.22% | 218B | |
| -0.28% | -4.66% | -1.64% | +11.28% | +17.51% | +26.99% | +92.98% | +113.74% | +89.25% | 179B | |
| -0.51% | -2.66% | -17.85% | -24.89% | -24.50% | -35.19% | -61.38% | -21.61% | +76.85% | 164B | |
| +0.33% | -4.25% | -1.04% | +15.94% | +10.44% | +4.05% | -16.99% | -34.55% | -18.28% | 156B | |
| -0.24% | -4.64% | -5.03% | -5.15% | +10.80% | +24.67% | +39.29% | +177.66% | +491.23% | 128B | |
| +1.33% | -5.20% | -7.88% | +5.10% | +10.47% | +32.01% | +5.17% | +0.68% | +8.25% | 120B | |
| +0.68% | +6.57% | +3.66% | +17.53% | +12.36% | +24.33% | +106.98% | +365.00% | +459.44% | 107B | |
| +0.89% | -1.93% | -7.41% | -6.86% | -14.64% | -18.65% | -31.35% | -15.40% | +2.72% | 93.99B | |
| +0.37% | -5.08% | -4.39% | -12.38% | -3.23% | +8.41% | +19.05% | +1.76% | -16.38% | 93.19B | |
| -7.75% | -7.86% | +33.59% | +129.17% | +535.67% | +580.68% | +80.46% | -38.01% | - | 81.13B | |
| +1.69% | -1.57% | -8.83% | +13.68% | -4.29% | +26.17% | -11.70% | +35.16% | +90.10% | 72.54B | |
| +2.17% | +0.40% | +2.32% | -4.57% | +13.38% | +15.02% | -10.06% | -25.43% | +44.72% | 66.31B | |
| Average | +0.33% | -2.83% | -1.24% | +7.21% | +35.24% | +47.44% | +33.25% | +75.17% | +193.87% | 250.76B | |
| Weighted average by Cap. | +0.67% | -3.24% | -0.96% | +2.08% | +19.88% | +34.16% | +53.70% | +138.21% | +395.25% |
- Stock Market
- Stocks
- KPTI Stock
- 25K0 Stock
- Sector Karyopharm Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
